Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Naiqing Ding"'
Autor:
Jia Wei, Xiaofeng Lu, Qin Liu, Yao Fu, Song Liu, Yang Zhao, Jiawei Zhou, Hui Chen, Meng Wang, Lin Li, Ju Yang, Fangcen Liu, Liming Zheng, Haitao Yin, Yang Yang, Chong Zhou, Ping Zeng, Xiaoyu Zhou, Naiqing Ding, Shiqing Chen, Xiaochen Zhao, Jing Yan, Xiangshan Fan, Wenxian Guan, Baorui Liu
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract In this multicenter, single-arm phase 2 trial (ChiCTR1900024428), patients with locally advanced gastric/gastroesophageal junction cancers receive one cycle of sintilimab (anti-PD1) and chemotherapy (S-1 and nab-paclitaxel), followed by 5 we
Externí odkaz:
https://doaj.org/article/1ecdf432190b4b00aedf65929a15ead2
Autor:
Ruihan Xu, Qin Wang, Junmeng Zhu, Yuncheng Bei, Yanhong Chu, Zhichen Sun, Shiyao Du, Shujuan Zhou, Naiqing Ding, Fanyan Meng, Baorui Liu
Publikováno v:
Bioengineering & Translational Medicine, Vol 8, Iss 6, Pp n/a-n/a (2023)
Abstract T cell receptor‐engineered T (TCR‐T) cell therapy has demonstrated therapeutic effects in basic research and clinical trials for treating solid tumors. Due to the peptide‐dependent recognition and the human leukocyte antigen (HLA)‐re
Externí odkaz:
https://doaj.org/article/8f35a83d63144ce2a913fb085e2edbeb
Autor:
Zhichen Sun, Rutian Li, Yun Shen, Siyi Tan, Naiqing Ding, Ruihan Xu, Xinyue Wang, Jia Wei, Baorui Liu, Fanyan Meng
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-15 (2022)
Abstract Background Chimeric antigen receptor (CAR)-T cell therapy has demonstrated remarkable success in the treatment of hematologic malignancies, while the success has not yet been replicated in solid tumors. To some extent, the disappointing resu
Externí odkaz:
https://doaj.org/article/e94ebc6db1874d60bd882dcbc3f0c6a7
Autor:
Naiqing Ding, Qin Liu, Juan Du, Jie Shao, Yang Yang, Ju Yang, Fangjun Chen, Lixia Yu, Baorui Liu, Jia Wei
Publikováno v:
Clinical & Translational Immunology, Vol 12, Iss 9, Pp n/a-n/a (2023)
Abstract Objectives The signet‐ring cell carcinoma (SRCC) of the stomach is highly invasive. Patients with stage III gastric SRCC usually experience tumor recurrence within 2 years after radical surgery. Unfortunately, there is no effective treatme
Externí odkaz:
https://doaj.org/article/4e8d6c42e2954c8fb3899f852f375dba
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Hepatoid adenocarcinoma of the duodenum is a rare special type of adenocarcinoma, featured by hepatocyte components in primary adenocarcinoma of the duodenum. It has the characteristics of high malignancy, invasiveness, rapid progress, and poor progn
Externí odkaz:
https://doaj.org/article/d709b722e3e640bb89dcb2d89772c113
Autor:
Jiayao Yan, Xiaoxiao Yu, Xiaotong Chen, Fangcen Liu, Fangjun Chen, Naiqing Ding, Lixia Yu, Fanyan Meng, Jie Shen, Jia Wei, Baorui Liu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Tumor-targeting peptides functioned as molecular probes are essential for multi-modality imaging and molecular-targeting therapy in caner theronostics. Here, we performed a phage-displayed bio-panning to identify a specific binding peptide targeting
Externí odkaz:
https://doaj.org/article/a042f3d7b80040c4a5356cecd8d943bf
Autor:
Huizi Sha, Naiqing Ding, Baorui Liu, Mei Zhu, Shujuan Zhou, Fanyan Meng, Shiyao Du, Hanqing Qian, Xiaoxiao Yu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background Poor infiltration and limited activation of transferred T cells are fundamental factors impeding the development of adoptive cell immunotherapy in solid tumors. A tumor-penetrating peptide iRGD has been widely used to deliver drugs deep in
Externí odkaz:
https://doaj.org/article/102283c908634adeac55f96a72fd6407
Autor:
Naiqing Ding, Zhengyun Zou, Huizi Sha, Shu Su, Hanqing Qian, Fanyan Meng, Fangjun Chen, Shiyao Du, Shujuan Zhou, Hong Chen, Lianru Zhang, Ju Yang, Jia Wei, Baorui Liu
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-9 (2019)
The therapeutic efficacy of adoptive T cell transfer is limited by their ability to infiltrate solid tumours. Here, the authors show that loading the tumor penetrating cyclic peptide iRGD on the cell surface of T cells enhances their ability to penet
Externí odkaz:
https://doaj.org/article/4d424ce982544f98bbf28d7feda3ba49
Autor:
Fangjun Chen1, Zhengyun Zou1, Juan Du1, Shu Su1, Jie Shao1, Fanyan Meng1, Ju Yang1, Qiuping Xu1, Naiqing Ding1, Yang Yang1, Qin Liu1, Qin Wang1, Zhichen Sun1, Shujuan Zhou1, Shiyao Du1, Jia Wei1, Baorui Liu1, Chen, Fangjun (AUTHOR), Zou, Zhengyun (AUTHOR), Du, Juan (AUTHOR)
Publikováno v:
Journal of Clinical Investigation. May2019, Vol. 129 Issue 5, p2056-2070. 15p.